Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications

AB Rowaiye, OA Okpalefe… - Journal of …, 2021 - Taylor & Francis
The COVID-19 pandemic constitutes an arduous global health challenge, and the
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …

Direct and indirect impact of COVID-19 for patients with immune-mediated inflammatory diseases: a retrospective cohort study

V Belleudi, AC Rosa, FR Poggi, A Armuzzi… - Journal of clinical …, 2021 - mdpi.com
Importance: Since the beginning of the Coronavirus Disease-19 (COVID-19) pandemic,
Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious …

Targeting cytokine storm to manage patients with COVID-19: a mini-review

N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …

[HTML][HTML] Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches

H Choi, EC Shin - BMB reports, 2022 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …

Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …

Hyperinflammation and immune response generation in COVID-19

KP Mishra, AK Singh, SB Singh - Neuroimmunomodulation, 2021 - karger.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes coronavirus
disease 2019 (COVID-19) pandemic has affected millions of people worldwide. The …

Immunomodulation as a potent COVID-19 pharmacotherapy: Past, present and future

DM Hertanto, BS Wiratama, H Sutanto… - Journal of …, 2021 - Taylor & Francis
In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …

Immune dysregulation and system pathology in COVID-19

M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun… - Virulence, 2021 - Taylor & Francis
ABSTRACT The coronavirus disease 19 (COVID-19) caused by the novel coronavirus
known as SARS-CoV-2 has caused a global public health crisis. As of 7 January 2021 …

Demystifying excess immune response in COVID-19 to reposition an orphan drug for down-regulation of NF-κB: a systematic review

A Peddapalli, M Gehani, AM Kalle, SR Peddapalli… - Viruses, 2021 - mdpi.com
The immunological findings from autopsies, biopsies, and various studies in COVID-19
patients show that the major cause of morbidity and mortality in COVID-19 is excess immune …

Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview

I Kudryavtsev, A Rubinstein, A Golovkin, O Kalinina… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in
humans more than two years ago and caused an unprecedented socio-economic burden on …